Piper Therapeutics
Cambridge, US · Founded 2015 · Delaware corporation
Founders & leadership
RJ
RUSSELL J. WILCOXExecutive
LS
LOIS SMITHNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 2 rounds · 2015–2016
▶$1.3MraisedMay 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedMay 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Russell J. WilcoxExecutive Officer, Director
- Lois SmithExecutive Officer
- Richard LimDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$200KraisedOct 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$200KraisedOct 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- RUSSELL J. WILCOXExecutive Officer, Director
- LOIS SMITHExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $200K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Piper Therapeutics raised?
- Piper Therapeutics has disclosed $1.5M raised across 2 rounds.
- Where is Piper Therapeutics headquartered?
- Piper Therapeutics is headquartered in Cambridge, US.